StockData
LivaNova PLC logo

LivaNova PLC (LIVN) stock

LIVNNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 13/3021% above fair value
$94.54+2.62 (+2.85%)

Close on Nov 18, 2026Market cap $5.21BP/E 27.9Yield –

LivaNova operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

LivaNova's operating cash flow for the twelve months ending Jun 30, 2026 was $249.26M, up 15.1% year over year. For fiscal 2025 it was $254.34M, up 39.0% from the year before. Over ten years it grew 16.7% a year on average. The highest annual figure on record is $254.34M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$254.34M+39.0%
FY2024Dec 31, 2024$183.04M+144.3%
FY2023Dec 31, 2023$74.91M+7.1%
FY2022Dec 31, 2022$69.92M-31.8%
FY2021Dec 31, 2021$102.54M–
FY2020Dec 31, 2020-$79.42M–
FY2019Dec 31, 2019-$91.14M-175.6%
FY2018Dec 31, 2018$120.49M+31.9%
FY2017Dec 31, 2017$91.34M+14.6%
FY2015Apr 24, 2015$79.68M+47.0%
FY2014Apr 25, 2014$54.20M-31.4%
FY2013Apr 26, 2013$79.05M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$66.59M+5.8%
Q1 FY2026CQ1 2026Mar 31, 2026$15.22M-36.5%
Q4 FY2025CQ4 2025Dec 31, 2025$82.40M+4.7%
Q3 FY2025CQ3 2025Sep 30, 2025$85.06M+66.8%
Q2 FY2025CQ2 2025Jun 30, 2025$62.92M+45.1%
Q1 FY2025CQ1 2025Mar 31, 2025$23.97M+140.1%
Q4 FY2024CQ4 2024Dec 31, 2024$78.71M+45.9%
Q3 FY2024CQ3 2024Sep 30, 2024$50.99M+181.2%
Q2 FY2024CQ2 2024Jun 30, 2024$43.36M–
Q1 FY2024CQ1 2024Mar 31, 2024$9.98M-51.9%
Q4 FY2023CQ4 2023Dec 31, 2023$53.96M+188.5%
Q3 FY2023CQ3 2023Sep 30, 2023$18.14M-49.1%
Q2 FY2023CQ2 2023Jun 30, 2023-$17.94M–
Q1 FY2023CQ1 2023Mar 31, 2023$20.76M-19.6%
Q4 FY2022CQ4 2022Dec 31, 2022$18.70M-44.1%
Q3 FY2022CQ3 2022Sep 30, 2022$35.64M+48.8%
Q2 FY2022CQ2 2022Jun 30, 2022-$10.24M-140.0%
Q1 FY2022CQ1 2022Mar 31, 2022$25.82M+32.6%
Q4 FY2021CQ4 2021Dec 31, 2021$33.48M-9.5%
Q3 FY2021CQ3 2021Sep 30, 2021$23.95M+176.7%
Q2 FY2021CQ2 2021Jun 30, 2021$25.63M–
Q1 FY2021CQ1 2021Mar 31, 2021$19.48M–
Q4 FY2020CQ4 2020Dec 31, 2020$36.99M+1190.5%
Q3 FY2020CQ3 2020Sep 30, 2020$8.66M–
Q2 FY2020CQ2 2020Jun 30, 2020-$19.02M–
Q1 FY2020CQ1 2020Mar 31, 2020-$106.05M-5472.1%
Q4 FY2019CQ4 2019Dec 31, 2019$2.87M-86.3%
Q3 FY2019CQ3 2019Sep 30, 2019-$76.59M-250.0%
Q2 FY2019CQ2 2019Jun 30, 2019-$19.40M-168.9%
Q1 FY2019CQ1 2019Mar 31, 2019$1.97M-90.3%
Q4 FY2018CQ4 2018Dec 31, 2018$20.89M+18.2%
Q3 FY2018CQ3 2018Sep 30, 2018$51.06M+21.3%
Q2 FY2018CQ2 2018Jun 30, 2018$28.14M–
Q1 FY2018CQ1 2018Mar 31, 2018$20.39M-38.6%
Q4 FY2017CQ4 2017Dec 31, 2017$17.67M+9.3%
Q3 FY2017CQ3 2017Sep 30, 2017$42.11M–
Q2 FY2017CQ2 2017Jun 30, 2017-$1.65M–
Q1 FY2017CQ1 2017Mar 31, 2017$33.21M–
Q4 FY2015CQ1 2015Apr 24, 2015$16.17M–

More LivaNova figures

See a number that looks wrong?